{"description":"Documents matching 'cannabis OR hemp OR cbd' and from Food and Drug Administration","count":3,"total_pages":1,"results":[{"title":"Use of Cannabis-Derived Products, Including Cannabidiol, in Veterinary Practice; Request for Information","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDPs) in animals, with an emphasis on cannabidiol (CBD) products and general trends associated with those products, including information about: usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns. This information will enhance the Center for Veterinary Medicine's (CVM's) knowledge of potential safety signals associated with these products, in addition to aiding our understanding of veterinarians' experiences related to the use of CDPs for their animal patients.","document_number":"2025-00945","html_url":"https://www.federalregister.gov/documents/2025/01/16/2025-00945/use-of-cannabis-derived-products-including-cannabidiol-in-veterinary-practice-request-for","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-16/pdf/2025-00945.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-00945.pdf?1736948743","publication_date":"2025-01-16","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"recommendations of <span class=\"match\">hemp</span>-derived <span class=\"match\">cannabis</span> products for your animal patients including: for what indications do you use or recommend <span class=\"match\">hemp</span>-derived <span class=\"match\">cannabis</span> products; for which species; and which dosage forms (\n e.g., \n oral, topical, inhalation), dose, brand, and cannabinoid(s) do you prefer? What information sources do you use to make these treatment decisions (continuing education, specialist recommendations, industry recommendations, etc.)? Describe any benefits of use related to <span class=\"match\">hemp</span>-derived <span class=\"match\">cannabis</span> products in your patients.\n \n \n 8. Related to <span class=\"match\">hemp</span>-derived"},{"title":"Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research.\" This draft guidance outlines FDA's current thinking on several topics relevant to the development of cannabis and cannabis- derived products: The source of cannabis and cannabis-derived compounds for clinical research; general quality considerations for developing drugs that contain cannabis and cannabis-derived compounds; and calculation of percent delta-9 tetrahydrocannabinol (THC) in botanical raw materials, extracts, and finished products. This draft guidance has been developed to help support clinical research into development of cannabis and cannabis-derived products.","document_number":"2020-15907","html_url":"https://www.federalregister.gov/documents/2020/07/22/2020-15907/cannabis-and-cannabis-derived-compounds-quality-considerations-for-clinical-research-draft-guidance","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-07-22/pdf/2020-15907.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-15907.pdf?1595335550","publication_date":"2020-07-22","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Agency) is announcing the availability of a draft guidance for industry entitled “<span class=\"match\">Cannabis</span> and <span class=\"match\">Cannabis</span>-Derived Compounds: Quality Considerations for Clinical Research.” This draft guidance outlines FDA's current thinking on several topics relevant to the development of <span class=\"match\">cannabis</span> and <span class=\"match\">cannabis</span>-derived products: The source of <span class=\"match\">cannabis</span> and <span class=\"match\">cannabis</span>-derived compounds for clinical research; general quality considerations for developing drugs that contain <span class=\"match\">cannabis</span> and <span class=\"match\">cannabis</span>-derived compounds; and calculation of percent delta-9 tetrahydrocannabinol (THC)"},{"title":"Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments","type":"Proposed Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.","document_number":"2019-06436","html_url":"https://www.federalregister.gov/documents/2019/04/03/2019-06436/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-04-03/pdf/2019-06436.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-06436.pdf?1554209119","publication_date":"2019-04-03","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"any data known that would support the safe use of <span class=\"match\">cannabis</span> and <span class=\"match\">cannabis</span>-related compounds in general food use (including dietary supplements), including data regarding exposure levels to <span class=\"match\">cannabis</span> and <span class=\"match\">cannabis</span>-related compounds in foods (including dietary supplements) that would be acceptable from a food safety perspective? \n \n • What data are available about residues of <span class=\"match\">cannabis</span>-derived compounds in human foods (\n e.g., \n meat, milk, or eggs) that come from animals that consume <span class=\"match\">cannabis</span> or <span class=\"match\">cannabis</span>-derived compounds? Are there residue levels that"}]}